[
  "Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company.",
  "Schleifer took Regeneron public in 1991; he owns nearly 4% of the company's common stock.",
  "Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, reached $4.6 billion in the U.S. in 2019.",
  "Regeneron has developed six FDA-approved medicines. ",
  "In June 2020, Regeneron began clinical trials of a new antibody medicine to prevent and treat people with Covid-19."
]